These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19398331)

  • 1. The application of the phosphoramidate ProTide approach confers micromolar potency against hepatitis C virus on inactive agent 4'-azidoinosine: kinase bypass on a dual base/sugar modified nucleoside.
    McGuigan C; Daverio F; Nájera I; Martin JA; Klumpp K; Smith DB
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3122-4. PubMed ID: 19398331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
    Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
    McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
    J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.
    Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
    McGuigan C; Perrone P; Madela K; Neyts J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoramidate protides of carbocyclic 2',3'-dideoxy-2',3'-didehydro-7-deazaadenosine with potent activity against HIV and HBV.
    Gudmundsson KS; Wang Z; Daluge SM; Johnson LC; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1929-37. PubMed ID: 15628749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue.
    Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C
    Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV.
    Gudmundsson KS; Daluge SM; Johnson LC; Jansen R; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1953-61. PubMed ID: 14609234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
    Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
    J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
    McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
    Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
    Mehellou Y; Balzarini J; McGuigan C
    ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
    Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
    ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTides.
    Mehellou Y; Balzarini J; McGuigan C
    Antivir Chem Chemother; 2010 Mar; 20(4):153-60. PubMed ID: 20231780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel synthesis of antiviral nucleoside phosphoramidate and thiophosphoramidate prodrugs via nucleoside H-phosphonamidates.
    Sun Q; Li X; Gong S; Liu G; Shen L; Peng L
    Nucleosides Nucleotides Nucleic Acids; 2013; 32(11):617-38. PubMed ID: 24138500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2'-C-methyl-6-O-methyl guanosine nucleoside and L-Alanine ester phosphoramidates.
    Bourdin C; McGuigan C; Brancale A; Chamberlain S; Vernachio J; Hutchins J; Gorovits E; Kolykhalov A; Muhammad J; Patti J; Henson G; Bleiman B; Bryant KD; Ganguly B; Hunley D; Obikhod A; Walters CR; Wang J; Ramamurty CV; Battina SK; Srivinas Rao C
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2260-4. PubMed ID: 23453067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.
    Chen Z; Cox BD; Garnier-Amblard EC; McBrayer TR; Coats SJ; Schinazi RF; Amblard F
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5296-5299. PubMed ID: 29066308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective synthesis of P-chirogenic phosphoramidate prodrugs of nucleoside analogues (ProTides) via copper catalysed reaction.
    Pertusati F; McGuigan C
    Chem Commun (Camb); 2015 May; 51(38):8070-3. PubMed ID: 25867944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartic acid based nucleoside phosphoramidate prodrugs as potent inhibitors of hepatitis C virus replication.
    Maiti M; Maiti M; Rozenski J; De Jonghe S; Herdewijn P
    Org Biomol Chem; 2015 May; 13(18):5158-74. PubMed ID: 25849139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus.
    McGuigan C; Madela K; Aljarah M; Gilles A; Brancale A; Zonta N; Chamberlain S; Vernachio J; Hutchins J; Hall A; Ames B; Gorovits E; Ganguly B; Kolykhalov A; Wang J; Muhammad J; Patti JM; Henson G
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4850-4. PubMed ID: 20637609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.